
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 47 as Sell-Off Deepens
2026-03-20 11:40:07For the fifth consecutive session, Krebs Biochemicals & Industries Ltd closed lower, slipping to a fresh 52-week low of Rs 47 on 20 Mar 2026, marking a 4.45% decline intraday despite opening with a modest gain. This latest drop extends the stock’s downward trajectory amid persistent underperformance relative to its sector and the broader market.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend
2026-03-19 16:00:07Krebs Biochemicals & Industries Ltd has touched a new 52-week low, closing just 2.22% above its lowest price of Rs 48.1, marking a significant milestone in its ongoing decline. Despite a modest 1.23% gain over the past two days, the stock remains under pressure, trading below all key moving averages amid a challenging market environment.
Read full news article
Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend
2026-03-17 10:50:02Krebs Biochemicals & Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.48.1 today, marking a significant decline in its stock price amid broader market movements and company-specific performance factors.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend
2026-03-16 14:30:06Krebs Biochemicals & Industries Ltd has declined to a new 52-week low, closing near Rs 52.5, marking a significant drop in its share price amid ongoing financial pressures and subdued market performance within the Pharmaceuticals & Biotechnology sector.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-03-13 10:10:14Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 March 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend
2026-03-09 16:01:28Krebs Biochemicals & Industries Ltd has declined to a new 52-week low, closing just 1.27% above its lowest price of Rs 50.5. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the share price retreating sharply after a brief two-day rally.
Read full news article
Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend
2026-03-06 10:14:55Krebs Biochemicals & Industries Ltd’s share price declined sharply to a new 52-week low of Rs.50.5 on 6 March 2026, marking a significant downturn amid broader sector and market pressures. The stock underperformed its Pharmaceuticals & Biotechnology sector peers and the broader market, reflecting ongoing financial and performance concerns.
Read full news article
Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend
2026-03-04 13:10:04Krebs Biochemicals & Industries Ltd has reached a new 52-week low, trading at Rs 57.08, marking a significant decline in its stock price over the past year. This development reflects ongoing pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-03-02 10:10:36Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
10-Feb-2026 | Source : BSEThe Company has enclosing copy of newspaper advertisement of financial results for the quarter ended 31.12.2025
Results Quarter Ended 31.12.2025
09-Feb-2026 | Source : BSEResult for the quarter ended 31.12.2025
Board Meeting Outcome for Outcome Of Board Meeting
09-Feb-2026 | Source : BSEOutcome of Board Meeting
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19






